Safety and Efficacy of Micafungin in Extremely Low Birth Weight Infants

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Little is known about the side effects of micafungin in extremely low birth weight infants. In a retrospective single-center study, 19 extremely low birth weight infants were analyzed for micafungin efficacy and safety. At a mean±standard deviation daily dosage of 7.5 ± 2.0 mg/kg, no clinically relevant side effects were observed. A significant increase of liver enzymes was reversible after treatment.

Original languageEnglish
Pages (from-to)e169-e172
JournalThe Pediatric Infectious Disease Journal
Volume37
Issue number6
DOIs
Publication statusPublished - 1 Jun 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Safety and Efficacy of Micafungin in Extremely Low Birth Weight Infants'. Together they form a unique fingerprint.

Cite this